Serum Institute, Merck & IAVI tie up to develop Covid-19 treatment therapy
Under IAVI’s agreement with Merck and Serum, the partners will conduct an accelerated, integrated program of preclinical and clinical research to evaluate the antibodies for treatment of Covid-19. Serum Institute of India has joined hands with Merck KGaA, Germany, and IAVI, a non-profit research organisation, to develop SARS-CoV-2 neutralising monoclonal antibodies (mAbs). This has been … Read more